封面
市場調查報告書
商品編碼
1544780

穀胱甘肽市場、機會、成長動力、產業趨勢分析與預測,2024-2032

Glutathione Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 180 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

由於人們對穀胱甘肽的健康益處,特別是其抗氧化特性的認知不斷提高,穀胱甘肽市場預計在 2024 年至 2032 年期間複合年成長率為 7.1%。它以其解毒特性和免疫支持而聞名。消費者對膳食補充劑的偏好以及向預防性醫療保健的轉變增強了對穀胱甘肽產品的興趣。例如,2024 年 4 月,印度著名植物性營養保健品牌 OZiva 推出了「Bioactive Gluta」碳酸飲料,以解決印度普遍存在的皮膚問題,並利用對穀胱甘肽不斷成長的需求。該產品旨在利用穀胱甘肽的抗氧化特性來對抗色素沉著並增強皮膚光澤。藥物和營養保健品配方的創新正在提高這些補充劑的可用性和功效,從而推動市場擴張。

隨著年齡的成長,天然穀胱甘肽水平下降,人們對維持健康和應對年齡相關問題的補充劑的興趣日益濃厚。這種人口結構的變化與個人化營養的趨勢一致,即消費者尋求適合其健康需求的產品。研究和臨床試驗一致強調穀胱甘肽在治療慢性疾病和皮膚病方面的益處,擴大了其市場吸引力。

整個穀胱甘肽市場根據產品、應用和地區進行細分。

氧化穀胱甘肽 (GSSG) 部分由於其在細胞氧化還原調節中的關鍵作用及其在醫療和美容領域的應用而獲得了巨大的關注。 GSSG 對於維持體內氧化壓力和抗氧化防禦之間的平衡至關重要。它在各個治療領域的重要性,包括其在治療神經退化性疾病和改善代謝健康方面的潛力,正在推動需求。此外,在化妝品中,GSSG 因其在亮膚和抗衰老療法中的作用而受到重視。人們對先進護膚解決方案和個人化醫療的興趣日益濃厚,推動了該細分市場的成長。

營養保健品的應用將對 2024-2032 年的市場成長產生正面影響。隨著對膳食補充劑的需求不斷上升,以其抗氧化特性和健康益處而聞名的穀胱甘肽正在被納入營養保健品配方中。它在支持排毒、免疫功能和整體健康方面的多功能性使其成為營養保健產品中的寶貴成分。預防性保健和個人化營養的不斷成長趨勢有利於將產品融入保健補充劑和功能性食品中。營養保健品應用的持續創新將進一步擴大穀胱甘肽的潛力,增加市場價值。

在整個地區健康意識不斷增強和可支配收入不斷增加的推動下,亞太地區穀胱甘肽市場預計到 2032 年將呈現強勁成長。不斷壯大的中產階級,加上人們對預防性醫療保健和健康日益成長的興趣,正在推動市場擴張。此外,中國、印度和日本蓬勃發展的製藥和化妝品產業也導致對穀胱甘肽產品的需求增加。為各種應用開發產品特性的持續研發努力將塑造未來幾年的區域市場前景。

目錄

第 1 章:方法與範圍

第 2 章:執行摘要

第 3 章:產業洞察

  • 產業生態系統分析
    • 價值鏈
    • 主要製造商
    • 前往市場路線
    • 主要經銷商
      • 新的分銷管道
    • 全行業利潤率
  • 產業影響力
    • 成長動力
    • 市場挑戰
    • 市場機會
      • 新市場/新應用
      • 成長潛力分析
  • 原料景觀
    • 製造趨勢
      • 技術演進
      • 永續製造
        • 綠色實踐
        • 脫碳
    • 新原料
    • 原物料價格走勢(美元/噸)
      • 美國
      • 歐洲聯盟
      • 英國
      • 中國
      • 東南亞
      • 海灣合作理事會
  • 法規和市場影響
  • 波特的分析
  • PESTEL分析

第 4 章:競爭格局

  • 公司市佔率分析
  • 競爭定位矩陣
  • 戰略展望矩陣

第 5 章:市場規模與預測:按產品分類,2021-2032 年

  • 主要趨勢
  • 穀胱甘肽減少
  • 氧化穀胱甘肽

第 6 章:市場規模與預測:按應用分類,2021-2032 年

  • 主要趨勢
  • 製藥
  • 化妝品
  • 營養保健品
  • 食物

第 7 章:市場規模與預測:按地區分類,2021-2032 年

  • 主要趨勢
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 亞太地區其他地區
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 拉丁美洲其他地區
  • MEA
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非
    • MEA 的其餘部分

第 8 章:公司簡介

  • Anhui GSH Bio-Technology Co., LTD
  • Cayman Chemical Company
  • Haihang Industry Co., Ltd.
  • Herbo Nutra
  • Kaiping Genuine Biochemical Pharmaceutical Co., Ltd
  • KOHJIN Life Sciences Co., Ltd.
  • Kyowa Hakko Bio Co., Ltd.,
  • Meteoric Biopharmaceuticals Pvt. Ltd.
  • Shandong Jincheng Biological Pharmaceutical Co., Ltd.
  • Xi'an Fengzu Biological Technology Co., Ltd
  • YAOPHARMA
簡介目錄
Product Code: 4147

The glutathione market is anticipated to register a 7.1% CAGR over 2024-2032, owing to heightened awareness of glutathione's health benefits, particularly its antioxidant properties. It is known for its detoxifying properties and immune support. The consumer inclination for dietary supplements and the shift towards preventive healthcare amplify interest in glutathione products. For instance, in April 2024, OZiva, a prominent Indian plant-based nutraceutical brand, introduced 'Bioactive Gluta' fizzy drink, to address prevalent skin issues in India and capitalize on the surging demand for glutathione. The product aims to combat pigmentation and enhance skin radiance using the antioxidative properties of glutathione. Innovations in pharmaceutical and nutraceutical formulations are enhancing the availability and efficacy of these supplements, thus propelling market expansion.

As people age, natural glutathione levels decline, increasing interest in supplements to maintain health and counter age-related issues. This demographic shift aligns with the trend in personalized nutrition, where consumers seek products tailored to their health needs. Research and clinical trials consistently highlight glutathione's benefits in managing chronic diseases and skin disorders, broadening its market appeal.

The overall glutathione market is segmented based on product, application, and region.

The glutathione oxidized (GSSG) segment is gaining significant traction due to its crucial role in cellular redox regulation and its applications in both medical and cosmetic fields. GSSG is essential for maintaining the balance between oxidative stress and antioxidant defense in the body. Its importance in various therapeutic areas, including its potential in treating neurodegenerative diseases and improving metabolic health, is driving demand. Additionally, in cosmetics, GSSG is valued for its role in skin brightening and anti-aging treatments. The rising interest in advanced skincare solutions and personalized medicine is contributing to the segment growth.

The nutraceutical application will positively influence the market growth over 2024-2032. As the demand for dietary supplements continues to rise, glutathione, renowned for its antioxidant properties and health benefits, is being incorporated into nutraceutical formulations. Its versatility in supporting detoxification, immune function, and overall wellness makes it a valuable ingredient in nutraceutical products. The rising trend of preventive healthcare and personalized nutrition is favoring product integration into health supplements and functional foods. The continued innovation in nutraceutical applications will further widen the potential of glutathione, adding to market value.

Asia Pacific glutathione market is estimated to display robust growth through 2032, driven by increasing health awareness and rising disposable incomes across the region. The expanding middle class, coupled with a growing interest in preventive healthcare and wellness, is fueling market expansion. Additionally, the burgeoning pharmaceutical and cosmetic industries in China, India, and Japan are contributing to the heightened demand for glutathione products. The constant R and D efforts to exploit the product properties for various applications will shape the regional market outlook in the coming years.

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definition
  • 1.2 Base estimates and calculations
  • 1.3 Forecast calculation
  • 1.4 Data sources
    • 1.4.1 Primary
    • 1.4.2 Secondary
      • 1.4.2.1 Paid sources
      • 1.4.2.2 Public sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
    • 3.1.1 Value chain
    • 3.1.2 Key manufacturers
    • 3.1.3 Go to market routes
    • 3.1.4 Key distributors
      • 3.1.4.1 New distribution channels
    • 3.1.5 Profit margins across the industry
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
    • 3.2.2 Market challenges
    • 3.2.3 Market opportunities
      • 3.2.3.1 New markets/applications
      • 3.2.3.2 Growth potential analysis
  • 3.3 Raw material landscape
    • 3.3.1 Manufacturing trends
      • 3.3.1.1 Technology evolution
      • 3.3.1.2 Sustainable manufacturing
        • 3.3.1.2.1 Green practices
        • 3.3.1.2.2 Decarbonization
    • 3.3.2 New raw materials
    • 3.3.3 Raw material pricing trends (USD/Ton)
      • 3.3.3.1 U.S.
      • 3.3.3.2 European Union
      • 3.3.3.3 UK
      • 3.3.3.4 China
      • 3.3.3.5 Southeast Asia
      • 3.3.3.6 GCC
  • 3.4 Regulations and market impact
  • 3.5 Porter's analysis
  • 3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Company market share analysis
  • 4.2 Competitive positioning matrix
  • 4.3 Strategic outlook matrix

Chapter 5 Market Size and Forecast, By Product, 2021-2032 (USD Billion, Kilo Tons)

  • 5.1 Key trends
  • 5.2 Glutathione reduced
  • 5.3 Glutathione oxidized

Chapter 6 Market Size and Forecast, By Application, 2021-2032 (USD Billion, Kilo Tons)

  • 6.1 Key trends
  • 6.2 Pharmaceutical
  • 6.3 Cosmetics
  • 6.4 Nutraceutical
  • 6.5 Food

Chapter 7 Market Size and Forecast, By Region, 2021-2032 (USD Billion, Kilo Tons)

  • 7.1 Key trends
  • 7.2 North America
    • 7.2.1 U.S.
    • 7.2.2 Canada
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 France
    • 7.3.4 Italy
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 China
    • 7.4.2 India
    • 7.4.3 Japan
    • 7.4.4 South Korea
    • 7.4.5 Australia
    • 7.4.6 Rest of Asia Pacific
  • 7.5 Latin America
    • 7.5.1 Brazil
    • 7.5.2 Mexico
    • 7.5.3 Argentina
    • 7.5.4 Rest of Latin America
  • 7.6 MEA
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 South Africa
    • 7.6.4 Rest of MEA

Chapter 8 Company Profiles

  • 8.1 Anhui GSH Bio-Technology Co., LTD
  • 8.2 Cayman Chemical Company
  • 8.3 Haihang Industry Co., Ltd.
  • 8.4 Herbo Nutra
  • 8.5 Kaiping Genuine Biochemical Pharmaceutical Co., Ltd
  • 8.6 KOHJIN Life Sciences Co., Ltd.
  • 8.7 Kyowa Hakko Bio Co., Ltd.,
  • 8.8 Meteoric Biopharmaceuticals Pvt. Ltd.
  • 8.9 Shandong Jincheng Biological Pharmaceutical Co., Ltd.
  • 8.10 Xi'an Fengzu Biological Technology Co., Ltd
  • 8.11 YAOPHARMA